ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

ASPO Honors Gritz.

May 25, 2001

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Ford Named Acting CORB Chief; Hunter CCOP Coordinator

July 10, 1987

NHIS Cancer Control Supplement To Survey 52,000

October 4, 1985

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000

Post Reporter Responds To Criticism Of Cancer Series

January 1, 1982